Who founded Vascudyne?

Vascudyne was founded by Robert T. Tranquillo, Zeeshan Syedain in 2014.

How much funding has Vascudyne raised?

Vascudyne has disclosed $19.6M raised across 2 rounds.

Where is Vascudyne headquartered?

Vascudyne is headquartered in Plano, US.

Vascudyne

Plano, US · Founded 2014 · Delaware corporation

Find your way into Vascudyne

Paths you didn't know you had: your email and LinkedIn already hold routes to the Vascudyne team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Vascudyne develops allograft tissue engineered from biological materials for regenerative medical applications, including heart valve therapies. The company advances non-immunogenic tissue solutions for clinical use.

Biotech Healthtech Medical Devices

Founders & leadership

Vascudyne was founded in 2014 by Robert T. Tranquillo and Zeeshan Syedain.

Robert T. TranquilloDirector of Congenial Heart Regeneration Program

Zeeshan SyedainCEOZeeshan Syedain is CEO of Vascudyne and co-inventor of bioengineered tissue technology developed at the University of Minnesota. He brings experience in medical device development, regulatory strategy, and clinical translation across cardiovascular applications.

Kemal SchakereliExecutive

Jeffrey D. FrancoExecutive

Jim NessExecutive

Reported raises · per SEC filings

Form D private placements

$19.6M disclosed across 2 rounds · 2015–2021

▶$17.7MraisedOct 2021 · 31 investors · Other Technology

Rule 506(b)

Officers, directors & promoters on the filing

Claude AmosDirector
Kemal SchankereliExecutive Officer, Director

Offering amount: $17.7M
Amount sold: $17.7M
Finders' fees: $506.2K
Placement agents: CSCAP ApS, Mirabaud Securities Ltd
First sale: Oct 2021
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$1.9MraisedMar 2017 · 3 investors · Other Technology

Rule 506(b)

Officers, directors & promoters on the filing

Kemal SchakereliExecutive Officer, Director
Jeffrey D. FrancoExecutive Officer, Director
Jim NessExecutive Officer

Offering amount: $1.9M
Amount sold: $1.9M
Minimum investment: $1
First sale: Jun 2015
Incorporated: Corporation, Delaware, 2014
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 1

SeamlessSeamless is a revenue operations platform that uses AI to automate sales outreach and contact verification for sales, marketing, and customer success teams. It identifies target buyers, verifies contact information in real time, and orchestrates multi-channel outreach via email, phone, and social media to generate meetings and pipeline.

Companies working in the same space as Vascudyne.

Frequently asked questions

What does Vascudyne do?: Vascudyne develops allograft tissue engineered from biological materials for regenerative medical applications, including heart valve therapies. The company advances non-immunogenic tissue solutions for clinical use.
Who founded Vascudyne?: Vascudyne was founded by Robert T. Tranquillo, Zeeshan Syedain in 2014.
How much funding has Vascudyne raised?: Vascudyne has disclosed $19.6M raised across 2 rounds.
Where is Vascudyne headquartered?: Vascudyne is headquartered in Plano, US.